Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency

Exclusion Criteria

• •1. Planned or current participation in another interventional clinical study that may confound the efficacy or safety evaluation of DTX301 during the duration of this study.
• •2. Any clinically significant medical condition that, in the opinion of the investigator, would pose a risk to subject safety or would impede the study.